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1. Introduction
Lower urinary tract symptoms (LUTS) refer to a series of symptoms due to 
bladder or urethral dysfunction and are basically divided into three groups: storage, 
voiding, and post-micturition symptoms [1]. Of those, storage symptoms include 
urinary urgency, increased daytime frequency, nocturia, and different types of 
urinary incontinence. Voiding symptoms include slow stream, splitting or spraying 
of the urine stream, intermittency, hesitancy, straining to void, and terminal dribble. 
Post-micturition symptoms include feeling of incomplete emptying and post-mictu-
rition dribble. A number of epidemiological studies reported the prevalence of LUTS 
that varies from country to country. EPIC study performed a population-based, 
cross-sectional survey in Canada, Germany, Italy, Sweden, and the United Kingdom 
using computer-assisted telephone interview and showed the overall prevalence of 
LUTS was approximate 64.3% [2]. The EpiLUTS study investigated the prevalence 
of LUTS in the USA, United Kingdom, and Sweden according to an Internet-based 
survey. The results revealed that the prevalence of at least one LUTS in male and 
female population was 72.3 and 76.3%, respectively [3]. Another study demonstrated 
that the prevalence in South Korea was 68.5%, which is higher than 59% in Mainland 
China and 58.5% in Taiwan [4]. The heterogeneity in LUTS prevalence may derive 
from the difference in genetic, diet, and lifestyle factors for people in different 
countries. In terms of the gender difference, some studies showed that storage LUTS 
were more common in women than in men, while voiding and post-micturition 
LUTS were more common in men than in women [3, 4]. Furthermore, women have 
a higher proportion to experience storage and voiding LUTS simultaneously in 
comparison with men. The difference in LUTS between male and female may result 
from the different anatomy of urethra. Men have an additional organ, prostate, and a 
longer urethra compared to women, which means men are more likely to experience 
bladder outlet obstruction than women. Due to the gender difference, it appears to be 
reasonable to only focus on single-gender population when designing a clinical trial 
or research about LUTS. Recently a number of clinical trials and research studies have 
emerged in the assessment and management of LUTS. With the evidence increas-
ing, it is worth considering how to apply these findings to clinical practice. We try to 
introduce the emerged evidence based on clinical practice from different aspects.
2. Clinical assessment for LUTS
It remains a challenge how to make an accurate assessment for LUTS and iden-
tify the potential causes since the etiology of LUTS is diverse. According to EAU 
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guideline, a number of conditions, including detrusor overactivity, underactive 
bladder, nocturnal polyuria, urethral stricture, etc., may contribute to male LUTS 
besides benign prostatic obstruction [5]. For female LUTS, increasing evidence 
shows that bladder outlet obstruction may play an important role in addition to 
pelvic floor dysfunction [6].
In general, physical examination can provide the helpful information for the 
etiological diagnosis of LUTS. Besides regular ones, bulbocavernosus reflex test 
is really useful to check the intactness of S2–S4 spinal reflex arc. Because sacral 
micturition center is located in S2–S4, this test is helpful to recognize the LUTS 
secondary to sacral or pudendal neuropathy. Additionally, the evaluation for pelvic 
floor function is essential for women with LUTS since it can identify the pelvic floor 
muscle tone, as well as the pelvic organ prolapse.
Traditionally, urodynamic study has been considered as a standard diagnostic 
tool for lower urinary tract dysfunction. Basically, urodynamic test contains filling 
cystometry (CMG) and pressure-flow studies (PFSs). The former is used to assess 
the storage function of the lower urinary tract, whereas the latter is used to evaluate 
the voiding function. Besides detecting bladder sensitivity, compliance, and detru-
sor overactivity, CMG can distinguish stress and urgency urinary incontinence. 
PFSs are normally used to diagnose bladder outlet obstruction. Furthermore, PFSs 
can also evaluate detrusor contraction, which is useful to find underactive bladder, 
a common cause of LUTS.
Despite advantages of urodynamic study, majority of patients tend to accept a 
noninvasive assessment compared to invasive urodynamic test. With the emergence 
of innovative imaging techniques, both anatomy and function of lower urinary 
tract can be assessed by noninvasive imaging approaches. In general, ultrasound 
is the most common technique to diagnose the lower urinary tract dysfunction. 
Some studies have shown that increased resistance of bladder contraction during 
the voiding phase in patients with bladder outlet obstruction (BOO) can result in an 
increase of bladder wall thickness (BWT), so can frequent detrusor overactive (DO) 
during the storage phase in patients with overactive bladder (OAB) [7, 8]. Based on 
this finding, a series of ultrasonographic parameters, including BWT, detrusor wall 
thickness (DWT), and ultrasound-estimated bladder weight (UEBW), have been 
used to diagnose BOO and DO. Furthermore, ultrasound strain imaging is also a suc-
cessful method to evaluate LUTS since it can monitor the change in the BWT during 
micturition in real time. In addition, near-infrared spectroscopy is a functional 
imaging technique which can detect changes in the concentration of oxygenated 
hemoglobin and deoxygenated hemoglobin in the bladder wall and consequently 
identify the DO and BOO. In comparison with ultrasound, MRI may provide 
additional important clue for the diagnosis of lower urinary tract dysfunction. Brain 
functional MRI is helpful to detect the neurologic lesions demerging bladder control. 
Dynamic MRI is able to detect the pelvic organ prolapse, as well as the urethral 
hypermobility, which cannot be found by physical examination or static MRI.
3. Management of LUTS
Successful management for LUTS is based on the deep understanding on specific 
symptoms and accurate diagnosis on potential cause of LUTS. For patients with 
predominant voiding LUTS, it is essential to distinguish between BOO and underac-
tive bladder (UAB). Once BOO is diagnosed clearly, α-blockers could be considered 
as the initial treatment. For male patients, if the BOO is secondary to significant 
enlarged prostate (>40 ml), 5α-reductase inhibitor is recommended to be added to 
shrink the prostate volume [5]. Moreover, there is increasing evidence to suggest 
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phosphodiesterase type 5 inhibitors (PDE5-Is) can relieve LUTS secondary to benign 
prostatic obstruction effectively though nitric oxide/cyclic guanosine monophosphate 
pathway (NO/cGMP). For patients who fail to respond to pharmacotherapy, minimal 
invasive surgical intervention, such as transurethral resection, could be an optional 
treatment. It is worth mentioning that urethral stricture is also a common cause of 
BOO and can be treated by urethral dilatation, internal urethrotomy, or urethroplasty 
depending on the characteristics of the stricture. The management of UAB, by con-
trast, is controversial because no regulatory approved specific therapy is available so 
far. Currently, the potential optional treatments for UAB include muscarinic agonists, 
regenerative therapy with mesenchymal stem cells or autologous muscle derived cells, 
gene therapy with myoblast injection, and neuromodulation [9].
In terms of patients with predominant storage LUTS, OAB is the most common con-
dition. Although behavioral interventions are recommended to be first-line treatment 
for OAB by guidelines, muscarinic antagonists and β3 agonists are normally used as the 
initial treatment in clinical practice. Once pharmacotherapy is unable to improve LUTS 
effectively, some invasive approaches including sacral neuromodulation, botulinum 
toxin type A intradetrusor injection, and posterior tibial nerve stimulation can be con-
sidered as the advanced therapeutic strategy. Urinary incontinence (UI) is another con-
dition related to storage LUTS, and successful management mainly relies on the precise 
identification for different types. Urgency UI can be managed by the approaches similar 
with the ones for OAB. Mid-urethral sling has been mainstream intervention for stress 
UI since the consolidated theory was proposed by Dr. DeLancey in 1996. Compared to 
pure stress or urgency UI, mixed UI is more difficult to treat since its complex etiol-
ogy. Today, the treatment only focuses on the main component of mixed UI. Besides 
conventional therapy, increasing high-level evidence demonstrates the effectiveness of 
complementary and alternative medicine on different types of UI [10, 11]. Nocturia is 
also a bothersome storage LUTS which not only can weaken patients’ quality of life but 
also may increase the risk of mortality. Management of nocturia had been a contro-
versial issue until the classification of nocturia was proposed, which allows clinicians 
to provide precision treatment for patients. It is reported that the main factors con-
tributing to nocturia include nocturnal polyuria and bladder capacity decline during 
nighttime. The former can be managed by desmopressin or diuretics, whereas the latter 
can be treated by muscarinic antagonists and β3 agonists. It is important to differenti-
ate nocturnal enuresis from nocturia in clinical practice, because both of them occur 
during the nighttime. The main difference between the two symptoms is whether the 
patient is accompanied by sleep arousal. Nocturnal enuresis occurs during sleep, while 
nocturia is presented in arousal. Moreover, nocturnal enuresis, also known as bed-wet-
ting, is more likely to present in children, while nocturia is common in adults. Similar to 
the pathogenesis of nocturia, nocturnal polyuria, and bladder capacity decline during 
nighttime are the potential pathogenesis of nocturnal enuresis too. Besides, arousal 
disorder also plays an important role for the occurrence of nocturnal enuresis. For this 
factor, alarm therapy could be helpful in waking the children up.
In summary, accurate clinical assessment is the prerequisite to manage LUTS 
successfully. Only with the sufficient understanding in characteristics and potential 
causes of LUTS can an individual management strategy be developed, which may 
optimize the treatment effect.
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